KarXT is a novel antipsychotic medication being developed by Karuna Therapeutics, focusing on M1 and M4 muscarinic receptors. It has the potential to address both positive and negative symptoms of ...
Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results